Hypofractionated radiation therapy for inoperable advanced stage non- small cell lung cancer

Tumori

Volumn 85, Issue 3, 1999, Pages 174-176

  Donato, Vittorio ^a,c   Zurlo, Alfredo ^b   Bonfili, Pierluigi ^a   Petrongari, Mariagrazia ^a   Santarelli, Mario ^a   Costa, Antonio ^a   Enrici, Riccardo Maurizi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c NONE   (Italy)

Author keywords

Advanced stage NSCLC; Hypofractionated radiotherapy; Palliative radiotherapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; HEMOPTYSIS; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SURVIVAL RATE;

EID: 0032810084     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169908500305     Document Type: Article

References (23)

1. Blanke C.D., Johnson D.H.: Combined modality therapy in non-small cell lung cancer. Current Opinion Oncol., 7: 144-149, 1995.
2. Bleehen N.M.: Randomised trial of two radiotherapy policies for patients with inoperable NSCLC and good performance status. Lung Cancer, 11: 131S, 1994.
3. Coia L.R., Owen J.B., Maher E.J., Hanks G.E.: Factors affecting treatment patterns of radiation oncologists in the United States in the palliative treatment of cancer. Clin. Oncol., 4: 6-10, 1992.
4. Cox J.D., Byhardt R.W., Komaki R.: The role of radiotherapy in squamous, large cell, and adenocarcinoma of the lung. Semin. Oncol., 10: 81-94, 1983.
5. Gregor A., Macbeth F.: Non-small cell lung cancer: are we out of step? Clin. Oncol., 7: 2-3, 1995.
6. Kjaer M.: Radiotherapy of squamous, adeno- and large cell carcinoma of the lung. Cancer Treat. Rev., 9: 1-20, 1982.
7. Kreisman H., Lisbona A., Olson L., Propert K., Modeas C., Dillman R., Seagre S., Green M.: Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer. Cancer, 72: 1588-1596, 1993.
8. Maher E.J., Timothy A., Squire C.J., Goodman A., Karp S.J., Paine C.H., Ryall R., Read G.: Audit: the use of radiotherapy for NSCLC in the UK. Clin. Oncol., 5: 72-79, 1993.
9. Medical Research Council Lung Cancer Working Party: A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer (NSCLC) and poor performance status. Br. J. Cancer, 65: 934-941, 1992.
10. Medical Research Council Lung Cancer Working Party: Inoperable non-small cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Br. J. Cancer, 63: 265-270, 1991.
11. Mountain C.: A new international staging system for lung cancer. Chest, 89: 225S-233S, 1986.
12. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ, 311: 899-909, 1995.
13. Petrovich Z., Stanley K., Cox J.D., Paig C.: Radiotherapy in the management of locally advanced lung cancer of all cell types. Cancer, 48: 1335-1340, 1981.
14. Pigott K.H., Saunders M.I.: The long term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lung. Clin. Oncol., 5: 350-354, 1993.
15. Saunders M., Dische S., Barrett A., Harvey A., Gibson D., Parmar M.: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. Lancet, 350: 161-165, 1997.
16. Shepherd F.A.: Treatment of advance non-small cell lung cancer. Semin. Oncol., 21: 7S-18S, 1994.
17. Simpson J.R., Francis M.E., Perez-Tamayo R., Marks R.D., Rao D.V.: Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int. J. Radiat. Oncol. Biol. Phys., 11: 751-758, 1985.
18. Slotman B.J., Njo K.H., de Jonge A., Meijer O.W.M., Karim A.B.M.F.: Hypofractionated radiation therapy in unresectable stage III non-small cell lung cancer. Cancer, 72: 1885-1893, 1995.
19. Sthephen R., Gibson D.: The impact of clinical trials on the treatment of lung cancer. Clin. Oncol., 5: 211-219, 1993.
20. Strauss G.M., Langer M.P., Elias A.D., Skarin A.T., Sugarbaker D.J.: Multimodality treatment of stage IIIA non-small cell lung carcinoma: a critical review of the literature and strategies for future research. J. Clin. Oncol., 10: 829-838, 1992.
21. Timothy A.R.: Treatment for lung cancer: who decides? Clin. Oncol., 5: 69-79, 1993.
22. Trovo M.G., Gigante M., Minatel E., Gobitti C., Franchin G.: Combined modality treatment of locally advanced lung cancer. Tumori, 84: 259-269, 1998.
23. Van Houtte P.: Stage III non-small cell lung cancer: still a challenge for the radiation oncologist. Int. J. Radiat. Oncol. Biol. Phys., 39: 533-535, 1997.